Results of bioequivalent data fabrication to be released

Published: 2006-09-27 06:59:00

Updated: 2006-09-27 06:59:00

The Korea Food and Drug Administration (KFDA) said it will unveil on September 28 the results of its ongoing investigation into 650 drugs from 1,250 bioequivalence-approved items, to check if pharmaceutical testing sites, including bio-venture companies and academic institutions, forged research ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK